Workflow
Edgewise Therapeutics Announces Pricing of $200 Million Underwritten Offering of Common Stock
EWTXEdgewise Therapeutics(EWTX) Prnewswire·2025-04-02 10:22

BOULDER, Colo., April 2, 2025 /PRNewswire/ -- Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a leading muscle disease biopharmaceutical company, today announced the pricing of an underwritten offering of 9,935,419 shares of its common stock at an offering price of 20.13pershare.Edgewiseanticipatesgrossproceedsfromtheofferingtobeapproximately20.13 per share. Edgewise anticipates gross proceeds from the offering to be approximately 200 million, before deducting underwriting discounts and commissions and offering expenses. The closing of the offering is expected to occur on April 3, 2025 ...